NEWTOWN, Pa.--(BUSINESS WIRE)--BioClinica®, Inc. (NASDAQ: BIOC), a global provider of clinical trial management services, today announced its financial results for the three and nine months ended September 30, 2010.
NEWTOWN, Pa.--(BUSINESS WIRE)--BioClinica®, Inc. (NASDAQ: BIOC), a global provider of clinical trial management services, today announced its financial results for the three and nine months ended September 30, 2010.